And Perovich must pore over the claims for antipsychotic drugs still to come: Bristol-Myers' (nyse: BMY - news - people ) aripiprazole and Novartis' (nyse: NVS - news - people ) Zomaril, both in final stage testing.

FORBES: Silencing the Voices